Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Controlling the time evolution of mAb N-linked glycosylation, Part I: Microbioreactor experiments

TK. Villiger, A. Roulet, A. Périlleux, M. Stettler, H. Broly, M. Morbidelli, M. Soos,

. 2016 ; 32 (5) : 1123-1134. [pub] 20160627

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016981

N-linked glycosylation is of key importance for the efficacy of many biotherapeutic proteins such as monoclonal antibodies (mAbs). Media components and cell culture conditions have been shown to significantly affect N-linked glycosylation during the production of glycoproteins using mammalian cell fed-batch cultures. These parameters inevitably change in modern industrial processes with concentrated feed additions and cell densities beyond 2 × 107 cells/mL. In order to control the time-dependent changes of protein glycosylation, an automated microbioreactor system was used to investigate the effects of culture pH, ammonia, galactose, and manganese chloride supplementation on nucleotide sugars as well as mAb N-linked glycosylation in a time-dependent way. Two different strategies comprising of a single shift of culture conditions as well as multiple media supplementations along the culture duration were applied to obtain changing and constant glycosylation profiles. The different feeding approaches enabled constant glycosylation patterns throughout the entire culture duration at different levels. By modulating the time evolution of the mAb glycan pattern, not only the endpoint but also the ratios between different glycosylation structures could be modified. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:1123-1134, 2016.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016981
003      
CZ-PrNML
005      
20180515103338.0
007      
ta
008      
180515s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/btpr.2305 $2 doi
035    __
$a (PubMed)27254475
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Villiger, Thomas K $u Dept. of Chemistry and Applied Biosciences, Inst. for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
245    10
$a Controlling the time evolution of mAb N-linked glycosylation, Part I: Microbioreactor experiments / $c TK. Villiger, A. Roulet, A. Périlleux, M. Stettler, H. Broly, M. Morbidelli, M. Soos,
520    9_
$a N-linked glycosylation is of key importance for the efficacy of many biotherapeutic proteins such as monoclonal antibodies (mAbs). Media components and cell culture conditions have been shown to significantly affect N-linked glycosylation during the production of glycoproteins using mammalian cell fed-batch cultures. These parameters inevitably change in modern industrial processes with concentrated feed additions and cell densities beyond 2 × 107 cells/mL. In order to control the time-dependent changes of protein glycosylation, an automated microbioreactor system was used to investigate the effects of culture pH, ammonia, galactose, and manganese chloride supplementation on nucleotide sugars as well as mAb N-linked glycosylation in a time-dependent way. Two different strategies comprising of a single shift of culture conditions as well as multiple media supplementations along the culture duration were applied to obtain changing and constant glycosylation profiles. The different feeding approaches enabled constant glycosylation patterns throughout the entire culture duration at different levels. By modulating the time evolution of the mAb glycan pattern, not only the endpoint but also the ratios between different glycosylation structures could be modified. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:1123-1134, 2016.
650    _2
$a zvířata $7 D000818
650    _2
$a monoklonální protilátky $x chemie $x metabolismus $7 D000911
650    12
$a bioreaktory $7 D019149
650    _2
$a CHO buňky $7 D016466
650    _2
$a kultivované buňky $7 D002478
650    _2
$a Cricetulus $7 D003412
650    _2
$a glykosylace $7 D006031
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Roulet, Anaïs $u Biotech Process Sciences, Merck-Serono S.A., Corsier-sur-Vevey, ZI B 1809, Switzerland.
700    1_
$a Périlleux, Arnaud $u Biotech Process Sciences, Merck-Serono S.A., Corsier-sur-Vevey, ZI B 1809, Switzerland.
700    1_
$a Stettler, Matthieu $u Biotech Process Sciences, Merck-Serono S.A., Corsier-sur-Vevey, ZI B 1809, Switzerland.
700    1_
$a Broly, Hervé $u Biotech Process Sciences, Merck-Serono S.A., Corsier-sur-Vevey, ZI B 1809, Switzerland.
700    1_
$a Morbidelli, Massimo $u Dept. of Chemistry and Applied Biosciences, Inst. for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
700    1_
$a Soos, Miroslav $u Dept. of Chemistry and Applied Biosciences, Inst. for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland. miroslav.soos@chem.ethz.ch. Dept. of Chemical Engineering, University of Chemistry and Technology, Prague, Czech Republic. miroslav.soos@chem.ethz.ch.
773    0_
$w MED00000800 $t Biotechnology progress $x 1520-6033 $g Roč. 32, č. 5 (2016), s. 1123-1134
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27254475 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103511 $b ABA008
999    __
$a ok $b bmc $g 1300605 $s 1013821
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 32 $c 5 $d 1123-1134 $e 20160627 $i 1520-6033 $m Biotechnology progress $n Biotechnol Prog $x MED00000800
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...